PubMed

Interpreting HIV serodiagnostic test results in the 1990s: social risks of HIV vaccine studies in uninfected volunteers. NIAID AIDS Vaccine Clinical Trials Group.

Belshe RB, Clements ML, Keefer MC, Graham BS, Corey L, Sposto R, Wescott S, Lawrence D.

Ann Intern Med. 1994 Oct 15;121(8):584-9.PMID: 8085690 [PubMed - indexed for MEDLINE]Related articlesFree article

HIV seroconversion without infection after receipt of adenovirus-vectored HIV type 1 vaccine.

Quirk EK, Mogg R, Brown DD, Lally MA, Mehrotra DV, DiNubile MJ, Robertson MN.

Clin Infect Dis. 2008 Dec 15;47(12):1593-9.PMID: 18990058 [PubMed - indexed for MEDLINE]Related articles

Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002.

Djomand G, Katzman J, di Tommaso D, Hudgens MG, Counts GW, Koblin BA, Sullivan PS.

Public Health Rep. 2005 Sep-Oct;120(5):543-8.PMID: 16224987 [PubMed - indexed for MEDLINE]Related articlesFree article

Preventing discrimination against volunteers in prophylactic HIV vaccine trials: lessons from a phase II trial.

Sheon AR, Wagner L, McElrath MJ, Keefer MC, Zimmerman E, Israel H, Berger D, Fast P.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 15;19(5):519-26.PMID: 9859967 [PubMed - indexed for MEDLINE]Related articles

Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies.

Khurana S, Needham J, Mathieson B, Rodriguez-Chavez IR, Catanzaro AT, Bailer RT, Kim J, Polonis V, Cooper DA, Guerin J, Peterson ML, Gurwith M, Nguyen N, Graham BS, Golding H.

J Virol. 2006 Mar;80(5):2092-9.PMID: 16474117 [PubMed - indexed for MEDLINE]Related articlesFree article

Human immunodeficiency virus (HIV) seropositivity among uninfected HIV vaccine recipients.

Ackers ML, Parekh B, Evans TG, Berman P, Phillips S, Allen M, McDougal JS.

J Infect Dis. 2003 Mar 15;187(6):879-86. Epub 2003 Feb 27.PMID: 12660933 [PubMed - indexed for MEDLINE]Related articles

Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation Group.

Belshe RB, Gorse GJ, Mulligan MJ, Evans TG, Keefer MC, Excler JL, Duliege AM, Tartaglia J, Cox WI, McNamara J, Hwang KL, Bradney A, Montefiori D, Weinhold KJ.

AIDS. 1998 Dec 24;12(18):2407-15.PMID: 9875578 [PubMed - indexed for MEDLINE]Related articles

Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials.

Gilbert PB, Chiu YL, Allen M, Lawrence DN, Chapdu C, Israel H, Holman D, Keefer MC, Wolff M, Frey SE; NIAID HIV Vaccine Trials Network.

Vaccine. 2003 Jun 20;21(21-22):2933-47.PMID: 12798637 [PubMed - indexed for MEDLINE]Related articles

False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. Retrovirus Epidemiology Donor Study.

Kleinman S, Busch MP, Hall L, Thomson R, Glynn S, Gallahan D, Ownby HE, Williams AE.

JAMA. 1998 Sep 23-30;280(12):1080-5.PMID: 9757856 [PubMed - indexed for MEDLINE]Related articlesFree article

Antibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines. The NIAID AIDS Vaccine Evaluation Group.

Gorse GJ, Patel GB, Newman FK, Belshe RB, Berman PW, Gregory TJ, Matthews TJ.

Clin Diagn Lab Immunol. 1996 Jul;3(4):378-86.PMID: 8807200 [PubMed - indexed for MEDLINE]Related articlesFree article

HIV gp120 vaccine - VaxGen: AIDSVAX, AIDSVAX B/B, AIDSVAX B/E, HIV gp120 vaccine - Genentech, HIV gp120 vaccine AIDSVAX - VaxGen, HIV vaccine AIDSVAX - VaxGen.

Adis International Ltd.

Drugs R D. 2003;4(4):249-53.PMID: 12848591 [PubMed - indexed for MEDLINE]Related articles

Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group.

Graham BS, Keefer MC, McElrath MJ, Gorse GJ, Schwartz DH, Weinhold K, Matthews TJ, Esterlitz JR, Sinangil F, Fast PE.

Ann Intern Med. 1996 Aug 15;125(4):270-9.PMID: 8678389 [PubMed - indexed for MEDLINE]Related articlesFree article

Trial-related discrimination in HIV vaccine clinical trials.

Allen M, Israel H, Rybczyk K, Pugliese MA, Loughran K, Wagner L, Erb S.

AIDS Res Hum Retroviruses. 2001 May 20;17(8):667-74.PMID: 11429107 [PubMed - indexed for MEDLINE]Related articles

Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine. The National Institute of Allergy and Infectious Diseases-sponsored AIDS Vaccine Evaluation Group.

Lambert JS, Viscidi R, Walker MC, Clayman B, Winget M, Wolff M, Schwartz DH.

Clin Diagn Lab Immunol. 1997 May;4(3):302-8.PMID: 9144368 [PubMed - indexed for MEDLINE]Related articlesFree article

Frequency of indeterminate western blot tests in healthy adults at low risk for human immunodeficiency virus infection. The NIAID AIDS Vaccine Clinical Trails Network.

Midthun K, Garrison L, Clements ML, Farzadegan H, Fernie B, Quinn T.

J Infect Dis. 1990 Dec;162(6):1379-82.PMID: 2230270 [PubMed - indexed for MEDLINE]Related articles

Domestic AIDS vaccine trials: addressing the potential for social harm to the subjects of human experiments.

Leider PA.

Calif Law Rev. 2000;88:1185-232.PMID: 11067733 [PubMed - indexed for MEDLINE]Related articles

Social impact of preventive HIV vaccine clinical trial participation: a model of prevention, assessment and intervention.

Allen M, Lau CY.

Soc Sci Med. 2008 Feb;66(4):945-51. Epub 2007 Dec 26.PMID: 18162272 [PubMed - indexed for MEDLINE]Related articles

Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.

Celentano DD, Beyrer C, Natpratan C, Eiumtrakul S, Sussman L, Renzullo PO, Khamboonruang C, Nelson KE.

AIDS. 1995 Sep;9(9):1079-83.PMID: 8527082 [PubMed - indexed for MEDLINE]Related articles

Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.

Sánchez-Ramón S, Bellón JM, Resino S, Cantó-Nogués C, Gurbindo D, Ramos JT, Muñoz-Fernández MA.

Pediatrics. 2003 Feb;111(2):E168-75.PMID: 12563091 [PubMed - indexed for MEDLINE]Related articlesFree article

HIV vaccine evaluation center in Rio de Janeiro, Brazil.

Schechter M.

Vaccine. 2002 May 6;20(15):1909-11. Review.PMID: 11983243 [PubMed - indexed for MEDLINE]Related articles